Why Investing in Pharmaceutical Industry Is Not Always The Right Idea

Elite
Coronavirus hit the world hard at a time when no one was ready for it. With a contagious disease harmful enough to cause deaths in millions, the absence of a vaccine caused a disaster. At such a time, India’s pharmaceutical industry played a huge role in the global market by exporting 723.435 lakh doses of COVID vaccine to 94 countries by the end of 2021. This was a powerful boost for the nation’s pharmaceutical industry and a subject of pride for the citizens.
The pharmaceutical industry has been a complex sector to analyse, whether it comes to finding the right medicine for a health issue or looking for the best company to invest in. There are too many obligations that this sector needs to follow, which complicates understanding the business model.
The little pills we swallow with one gulp take 10+ years to come to our palms. The journey of that pill from a researcher’s notebook to the chemist’s shop goes through a strict set of regulations which are essential to follow due to safety concerns. These regulations give birth to various sectors in the pharmaceutical industry, making the entire sector puzzling.
You are missing out on so much.
To continue reading, Subscribe.
You can have unlimited access to all the Elite Articles. Log in to check if your Finology account is ready for Elite.
By Subscribing to Finology One, you can unlock more superpowers -
Up to 3 premium articles every week
15+ Stock recommendations with Recipe.
45+ premium courses with Quest.
Valuation Calculators and more tools with Ticker.
You get all of these in one, with One.